Nickoloff E
Administrative Resources, E.R. Squibb & Sons, Inc., Princeton, New Jersey.
Crit Rev Clin Lab Sci. 1988;26(4):263-76. doi: 10.3109/10408368809105892.
With the advent of binding assays for vitamin B12 in blood, the Schilling test, which involves administration of radioactive B12 to a patient and subsequent urine collection for 24 to 48 h, fell into disuse in many laboratories. However, the test is still the only way to actually measure whether vitamin B12 is being absorbed through the terminal ilium. By administering radioactive vitamin B12, along with a preparation of intrinsic factor (IF), lack of functional IF may also be demonstrated. The Schilling test requires that attention be paid to a number of parameters, including the amount of radioactive vitamin B12 administered and the completeness of the urine collection. These factors, and others required for correct performance of the test, are discussed in this article.
随着血液中维生素B12结合测定法的出现,希林试验(该试验包括给患者服用放射性B12,随后收集24至48小时的尿液)在许多实验室已不再使用。然而,该试验仍然是实际测量维生素B12是否通过回肠末端被吸收的唯一方法。通过给予放射性维生素B12以及内因子(IF)制剂,也可以证明内因子功能缺乏。希林试验需要注意一些参数,包括所给予的放射性维生素B12的量以及尿液收集的完整性。本文将讨论这些因素以及正确进行该试验所需的其他因素。